SEC Form 4
Nephros Inc. (NEPH) insider trading
In the 12 months to Nov 19, 2026, one NEPH insider reported open-market purchases of $22.1K across 1 filing; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $22.1K
- 1 filing · Arthur H. Amron, Director
Who traded NEPH, and when
- Purchase
NEPH daily close from Nov 19, 2025 to Nov 18, 2026, between $2.78 and $5.79, last $2.89. 0 sale and 1 purchase filings by 1 insider, marked at their filing dates. Arthur H. Amron, Director: bought $22.1K across 1 filing, first filed Nov 18, 2026, last Nov 18, 2026.
Largest mark · tap a row for others
Arthur H. Amron · Director
Purchase $22,075
7,500 shares at $2.94 avg
Filed Nov 18, 2026 · traded Nov 16
Close on filing date $2.89
Arthur H. Amron · Director
Director
$22.1K boughtOpen-market trades
1 filing in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Arthur H. Amron | Director | — | $22.1K | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Arthur H. Amron Director | Purchase | 7,500 | $2.94 | $22.1K | 169,637 |
GET /stocks/filings/vX/form-4?tickers=NEPH&filing_date.gte=2025-11-19&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"NEPH"
],
"issuer_cik": "0001196298",
"owner_cik": "0001179697",
"accession_number": "0000914190-26-000181",
"form_type": "4",
"filing_date": "2026-11-18",
"period_of_report": "2026-11-16",
"issuer_name": "NEPHROS INC",
"issuer_trading_symbol": "NEPH",
"owner_name": "Amron Arthur H",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-11-17",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 2500,
"transaction_price_per_share": 2.84,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 169637,
"transaction_value": 7100,
"direct_or_indirect": "D"
},
{
"tickers": [
"NEPH"
],
"issuer_cik": "0001196298",
"owner_cik": "0001179697",
"accession_number": "0000914190-26-000181",
"form_type": "4",
"filing_date": "2026-11-18",
"period_of_report": "2026-11-16",
"issuer_name": "NEPHROS INC",
"issuer_trading_symbol": "NEPH",
"owner_name": "Amron Arthur H",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-11-16",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 5000,
"transaction_price_per_share": 2.995,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 167137,
"transaction_value": 14975,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F2",
"description": "The price reported in Column 4 is a weighted average price. These shares were purchased in two transactions at prices of $2.99 and $3.00, inclusive. The reporting person undertakes to provide to Nephros, Inc., any security holder of Nephros, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 13 records
- Option exercises3 records
- Grants and awards5 records
- Other5 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Nephros Inc.'s CEO sold stock?
No. Robert R. Banks JR. (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is NEPH’s insider data?
These are NEPH Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track NEPH insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for NEPH every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.